All News about 4D Molecular Therapeutics, Inc. - Common Stock
What 5 Analyst Ratings Have To Say About 4D Molecular Therapeutics
December 18, 2024
Via Benzinga
Via Benzinga
Analyst Expectations For 4D Molecular Therapeutics's Future
November 14, 2024
Via Benzinga
The Latest Analyst Ratings For 4D Molecular Therapeutics
September 09, 2024
Via Benzinga
4DMT Announces Presentations at Upcoming Retina Conferences
September 05, 2024
Via GlobeNewswire
4DMT to Participate in the 2024 Cantor Global Healthcare Conference
September 03, 2024
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|